|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 273,500.00 KRW | -1.97% |
|
+17.63% | +18.66% |
| 07-01 | Galderma Hits FDA Setback Again in Bid to Launch Botox Rival in U.S. -- Update | DJ |
| 05-14 | Hugel, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 279,000 | 295,000 | 332,000 |
| Spread/Res. | -1.97% | -7.29% | -17.62% |
| Spread/Supp. | +12.55% | +23.48% | +27.80% |
| Support | 243,000 | 221,500 | 214,000 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- A145020 Stock
- Charts Hugel, Inc.
Select your edition
All financial news and data tailored to specific country editions
